Search Results - "Thongsin, Nontaphat"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    A three-dimensional immune-oncology model for studying in vitro primary human NK cell cytotoxic activity by Thongsin, Nontaphat, Wattanapanitch, Methichit

    Published in PloS one (21-03-2022)
    “…Immunotherapy has emerged as a promising therapeutic approach for treating several forms of cancer. Adoptive cell transfer of immune cells, such as natural…”
    Get full text
    Journal Article
  2. 2

    A precise gene delivery approach for human induced pluripotent stem cells using Cas9 RNP complex and recombinant AAV6 donor vectors by Chupradit, Koollawat, Thongsin, Nontaphat, Tayapiwatana, Chatchai, Wattanapanitch, Methichit

    Published in PloS one (07-07-2022)
    “…Genome editing in human induced pluripotent stem cells (hiPSCs) offers a potential tool for studying gene functions in disease models and correcting genetic…”
    Get full text
    Journal Article
  3. 3

    Generation of a homozygous TIGIT gene knockout (TIGIT−/−) human iPSC line (MUSIi001-A-3) using CRISPR/Cas9 system by Srisantitham, Jakkrapatra, Suwanpitak, Siriwal, Thongsin, Nontaphat, Wattanapanitch, Methichit

    Published in Stem cell research (01-12-2024)
    “…Adoptive cell therapy for solid cancers involves enhancing and reinfusing immune cells to target tumor cells. The advancement of induced pluripotent stem cell…”
    Get full text
    Journal Article
  4. 4

    Generation of B2M bi-allelic knockout human induced pluripotent stem cells (MUSIi001-A-1) using a CRISPR/Cas9 system by Thongsin, Nontaphat, Wattanapanitch, Methichit

    Published in Stem cell research (01-10-2021)
    “…Allogeneic cell-based therapy is emerging as a promising approach in regenerative medicine. However, rejection of allograft due to mismatch of human leukocyte…”
    Get full text
    Journal Article
  5. 5

    CRISPR-Cas9-mediated disruption of B2M and CIITA genes eliminates HLA class I and II expression in human induced pluripotent stem cells (MUSIi001-A-2) by Thongsin, Nontaphat, Suwanpitak, Siriwal, Wattanapanitch, Methichit

    Published in Stem cell research (01-09-2023)
    “…Cell-based therapy offers great promise for treating degenerative diseases. Although autologous cell-based therapy is ideal, it may be impractical due to the…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Genetic correction of haemoglobin E in an immortalised haemoglobin E/beta-thalassaemia cell line using the CRISPR/Cas9 system by Trakarnsanga, Kongtana, Thongsin, Nontaphat, Metheetrairut, Chanatip, Tipgomut, Chartsiam, Poldee, Saiphon, Wattanapanitch, Methichit

    Published in Scientific reports (16-09-2022)
    “…β-thalassaemia is one of the most common genetic blood diseases worldwide with over 300 mutations in the HBB gene affecting red blood cell functions. Recently,…”
    Get full text
    Journal Article
  8. 8

    Phenotypic and transcriptomic profiling of induced pluripotent stem cell (iPSC)-derived NK cells and their cytotoxicity against cancers by Thongsin, Nontaphat, Suwanpitak, Siriwal, Augsornworawat, Punn, Srisantitham, Jakkrapatra, Saiprayong, Kritayaporn, Jenjaroenpun, Piroon, Wattanapanitch, Methichit

    Published in Stem cell research & therapy (13-11-2024)
    “…Adoptive immunotherapy using natural killer (NK) cells has attracted considerable interest in numerous clinical trials targeting both hematological and solid…”
    Get full text
    Journal Article
  9. 9
  10. 10

    CRISPR/Cas9-Mediated GFP Reporter Knock-in in K562 and Raji Cell Lines for Tracking Immune Cell Killing Assay by Thongsin, Nontaphat, Wattanapanitch, Methichit

    “…Cell-mediated cytotoxicity plays an important role in several fundamental immunological processes and is crucial for biological evaluation in in vitro studies…”
    Get more information
    Journal Article
  11. 11

    A three-dimensional immune-oncology model for studying in vitro primary human NK cell cytotoxic activity by Nontaphat Thongsin, Methichit Wattanapanitch

    Published in PloS one (01-01-2022)
    “…Immunotherapy has emerged as a promising therapeutic approach for treating several forms of cancer. Adoptive cell transfer of immune cells, such as natural…”
    Get full text
    Journal Article
  12. 12

    Doxorubicin sensitizes breast cancer cells to natural killer cells in connection with increased Fas receptors by Sawasdee, Nunghathai, Wattanapanitch, Methichit, Thongsin, Nontaphat, Phanthaphol, Nattaporn, Chiawpanit, Chutipa, Thuwajit, Chanitra, Yenchitsomanus, Pa-Thai, Panya, Aussara

    “…Breast cancer (BC) is the most common cancer in women. Although standard treatments are successful in patients with BC diagnosed at an early stage, an…”
    Get full text
    Journal Article
  13. 13

    High diversity of Blastocystis subtypes isolated from asymptomatic adults living in Chiang Rai, Thailand by Yowang, Amara, Tsaousis, Anastasios D., Chumphonsuk, Tawatchai, Thongsin, Nontaphat, Kullawong, Niwed, Popluechai, Siam, Gentekaki, Eleni

    Published in Infection, genetics and evolution (01-11-2018)
    “…Blastocystis is a common and broadly distributed microbial eukaryote inhabiting the gut of humans and other animals. The genetic diversity of Blastocystis is…”
    Get full text
    Journal Article